Posted On: 01/14/2014 9:10:29 AM
Post# of 94264
$NVLX ~ Dr. Hyslop's experience with cancer drugs and enzymology could prove to be invaluable in pursuing the goals of Medical Marijuana Sciences that include developing treatments, which employ constituents of Cannabis together with the Cell-in-a-Box™ cellulose-based live-cell encapsulation technology, whose rights were acquired by Nuvilex in 2013, for some of the deadliest forms of cancer. Dr. Hyslop’s location in the most high profile state in the country that has legalized the use of marijuana for medicinal purposes could be a further boon to the Company’s R&D efforts.
(0)
(0)
